Abstract
The purpose . We aimed to develop, implement and evaluate the efficiency of a novel clinical and organization approach to the medical prevention of cardiovascular diseases in primary health care settings. Material and methods. The comparative assessment of the results of dispensary observation of patients with AH was conducted in the main group (n=308) who underwent a novel prevention program and in the control group (n=240) who were under the usual supervision of a general practitioner. The mean age of the patients in the groups was 59.0±10.8 and 57.5±10.47 years respectively. The basis of the novel prevention technology is the assessment of cardiovascular risk and the development of patients’ itinerary at the pre-hospital stage using the medical information system. Results. In the group with AH who underwent a novel prevention program, a number of patients who had achieved the target systolic and diastolic blood pressure and target cholesterol level was significantly higher than in the control group. The patients of the main group visited a hospital for AH decompensation significantly less frequent. The patients in the main group were more compliant with diagnostic tests and consultations of the specialists as compared to the patients in the control group. The patients of the main group more often attended the classes of the School of Health included into the prevention program. The duration of the observation period was 12±6.5 months. Conclusion . The study proved that the individual prevention program at the pre-hospital stage reduced the prevalence and the severity degree of cardiovascular risk factors and increased the number of patients who had reached the target values of the controlled risk factors after 12±6.5 months of observation. It is achieved by the compliance with requirements of the Russian guidelines and the higher adherence of patients to the preventive measures.
Highlights
DпEаVциEеLнOтоPвMсEАNГ вTкOолFиTчеISстSвUе 3E0E8 NчеGлоINвеEкE(RосEнDовSнаMяAгрLуLппDаI)A, пMолEуTчEивRшVиAх нSаCбUлюLдAеRниGе RпоAнFоTвой технологии медицинской профиFлаOкRтикTиH, иE2C40AпRаDциIOенVтAовSкCоUнтLрAоRльSноUйRгрGуEпRпыY, кNоEтоEрDыSе находились под обычным диспансерным наблюдением участкового врача
Implement and evaluate the efficiency of a novel clinical and organization approach to the medical prevention of cardiovascular diseases in primary health care settings
The comparative assessment of the results of dispensary observation of patients with AH was conducted in the main group (n=308) who underwent a novel prevention program and in the control group (n=240) who were under the usual supervision of a general practitioner
Summary
DпEаVциEеLнOтоPвMсEАNГ вTкOолFиTчеISстSвUе 3E0E8 NчеGлоINвеEкE(RосEнDовSнаMяAгрLуLппDаI)A, пMолEуTчEивRшVиAх нSаCбUлюLдAеRниGе RпоAнFоTвой технологии медицинской профиFлаOкRтикTиH, иE2C40AпRаDциIOенVтAовSкCоUнтLрAоRльSноUйRгрGуEпRпыY, кNоEтоEрDыSе находились под обычным диспансерным наблюдением участкового врача. Средний возраст пациентов в группах составил 59,0±10,8 и 57,5±10,47 лет соответственно. KилUаDкRтиYкAиV−TSоEцVеAнка сердечно-сосудистого риска и разработка маршрута пацFиeеdнeтrаaнl аSдtaоtвeрBачuеdбgнeоtaмryэтSаcпiеeсntпifрicимInеsнtеitнuиtеioмnмRеeдsиeцaиrнcсhкIоnйstиitнuфteормационной системы. Kдeеmниeеroпvоoн, оRвuоsйsiтaехнологии медицинской профилактики, достоверно чаще отмечалось достижение целевого уровня систолического артериального давления RICIC(dСАhaДs)lиargдeиаexсpтeоrлieиnчcеeсinкоthгeоdаeрveтеloрpиmаeлnьt oнfоpгrоodдuаcвtsлfеoнr иcaяrd(ДioАvaДsc),uцlaеrлsеuвrgоeгrоy, уinрpоaвrtнicяulхaоr,лthеeстbеioрpиroнsаth(eХsСis),hчeеaмrt vвalкvоesнтрольной and blood veгрssуeпlsп.еS. В основvraeappsplcaroucaleacrihnpdforiovrнсiscdуtоruheлйaeaьlstгтseioраtsrnцуuoпaиcftnпйusеormeсrиgsпaaсеollnсfцdлadиiеairlаimeдvлciоenиtltgвyeсаorтinноrbgtивehaяgenвaiоpsnсamт.рtмi,tаeiеhnnвчetнp’sаaеpлbrнrtсoiimиcdяuиyaбlrabyсоry,лкpobеоufiorенcpfauтвornрsdыceоiotсiлovо–aьnкstaнoиclойuacйlnraпed.rрaПsbtоyаieosццrtpeeеиosmнеloyт.нrmbSитaecысbrieпlоesnоtсtfriлeufнiнaccоttеnuuвнorrнeevиssоeяlйotwyдf iгptиohрofауltybгhпmiнeoпоe-pdыrсrisorтeчtbиrcаulчetщcemеtduсеlrкiaeeпиcssоt.хiioсtnиnеhuсщecsсailаnлopлgnеagидab-оltзneeваertmаwнoняитийяиШкокон-patency of PлCыL vзaдsоcрulоarвgьrяa,ftвsкaлnюd чPеHнBнVыaеndвPпCрLоcфoиmлpаoкsiтtiиoчnеgсraкfуtsюhпadроprгoрvаeмd.мtуh.eПinроviдtrоo лeжxpиeтriеmлeьnнtsоhсaтdьpнrаoбveлdюtдhaеtнgиroяw1th2±fa6c,t5orмs есяцев. Епень выKey wрoаrжdsе:нbнioоdсeтgиraфdaаbкlтeоpрoоlyвmрerиsс, кaаvaсsеcрuдlaеrчgнraоf-t,сgоrсoуwдthисfaтcыtoхrsз.аболеваний, повышает долю пациентов, достигших целевых значений управляемых факторов риска. Это достигается за счет соблюдения требований российских рекомен-. НИИ КдПацСиСйЗиибмоелеьтшебйолпьршивоейржопеыннтовстриапзарцаибеонтт-ов к пнроогфоишлаукнттиичреосквиамнимяе,риопврсиляетдисятмв.ие отсутствия на ке изделий Кдллюя чсееврыдеечснлоо-всао.сМудеидситцоийнскхаиярупрргоифии,лактиркыа,ндкиеспсаонссуедринсотеынхабилмюпдлеаннитеа,тфоавк,топррыигроидснкыа,хседрлдяечно-сосув частносдтиисбтыиеопзарбоотелзеовванкиляа,паарнтеорвисаелрьднцаая гиипсоерсуте-нзияа. Ортокоронарного шунтирования, в 2010 году под дов. Разработка биологических протезов клапана руководством академика РАН Л. Implement and evaluate the efficiency of a novel clinical and organization approach to the medical prevention of cardiovascular diseases in primary health care settings
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
